[go: up one dir, main page]

GB2552271B - A method for diagnosing lung cancer - Google Patents

A method for diagnosing lung cancer Download PDF

Info

Publication number
GB2552271B
GB2552271B GB1713637.5A GB201713637A GB2552271B GB 2552271 B GB2552271 B GB 2552271B GB 201713637 A GB201713637 A GB 201713637A GB 2552271 B GB2552271 B GB 2552271B
Authority
GB
United Kingdom
Prior art keywords
lung cancer
diagnosing lung
diagnosing
cancer
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1713637.5A
Other versions
GB2552271A (en
GB201713637D0 (en
Inventor
Alejandro Jose Mur Luis
John Cameron Simon
Ann Huws Sharon
A Pachebat Justin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aberystwyth University
Original Assignee
Aberystwyth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aberystwyth University filed Critical Aberystwyth University
Publication of GB201713637D0 publication Critical patent/GB201713637D0/en
Publication of GB2552271A publication Critical patent/GB2552271A/en
Application granted granted Critical
Publication of GB2552271B publication Critical patent/GB2552271B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1713637.5A 2014-12-19 2015-12-18 A method for diagnosing lung cancer Active GB2552271B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201422850 2014-12-19
PCT/GB2015/054093 WO2016097769A1 (en) 2014-12-19 2015-12-18 A method for diagnosing lung cancer

Publications (3)

Publication Number Publication Date
GB201713637D0 GB201713637D0 (en) 2017-10-11
GB2552271A GB2552271A (en) 2018-01-17
GB2552271B true GB2552271B (en) 2020-10-21

Family

ID=55069007

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1713637.5A Active GB2552271B (en) 2014-12-19 2015-12-18 A method for diagnosing lung cancer

Country Status (2)

Country Link
GB (1) GB2552271B (en)
WO (1) WO2016097769A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108070656B (en) * 2017-11-13 2021-11-09 深圳华大因源医药科技有限公司 Lung cancer marker and application thereof
US11331269B2 (en) 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
BR112021012073A2 (en) * 2018-12-21 2021-10-19 Biomark Cancer Systems Inc. BIOMARKER PANEL, AND, USE OF THE BIOMARKER PANEL
KR20240105412A (en) 2021-11-05 2024-07-05 사노피 파스퇴르 인크 Multivalent influenza vaccine comprising recombinant hemagglutinin and neuraminidase and method of using the same
WO2023079113A1 (en) 2021-11-05 2023-05-11 Sanofi Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1770171A1 (en) * 2005-09-29 2007-04-04 Universität Zu Köln DNA microarray for rapid identification of Candida albicans in blood cultures.
WO2011100483A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary biomarkers for lung cancer detection
WO2012117431A1 (en) * 2011-03-03 2012-09-07 Molecular Digital Diagnostics S.R.L. Method and reagent kit for the identification of biological fluids in a sample

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1770171A1 (en) * 2005-09-29 2007-04-04 Universität Zu Köln DNA microarray for rapid identification of Candida albicans in blood cultures.
WO2011100483A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary biomarkers for lung cancer detection
WO2012117431A1 (en) * 2011-03-03 2012-09-07 Molecular Digital Diagnostics S.R.L. Method and reagent kit for the identification of biological fluids in a sample

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PANAGIOTIS APOSTOLOU;AGGELIKI TSANTSARIDOU;IOANNIS PAPASOTIRIOU;MARIA TOLOUDI;MARINA CHATZIIOANNOU;GREGORY GIAMOUZIS: "Bacterial and fungal microflora in surgically removed lung cancer samples", JOURNAL OF CARDIOTHORACIC SURGERY, BIOMED CENTRAL LTD, LO, vol. 6, no. 1, 14 October 2011 (2011-10-14), Lo, pages 137, XP021114209, ISSN: 1749-8090, DOI: 10.1186/1749-8090-6-137 *
SMRUTI PUSHALKAR;XIAOJIE JI;YIHONG LI;CHERRY ESTILO;RAMANATHAN YEGNANARAYANA;BHUVANESH SINGH;XIN LI;DEEPAK SAXENA: "Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma", BMC MICROBIOLOGY, BIOMED CENTRAL LTD., GB, vol. 12, no. 1, 20 July 2012 (2012-07-20), GB, pages 144, XP021120064, ISSN: 1471-2180, DOI: 10.1186/1471-2180-12-144 *

Also Published As

Publication number Publication date
GB2552271A (en) 2018-01-17
WO2016097769A1 (en) 2016-06-23
GB201713637D0 (en) 2017-10-11

Similar Documents

Publication Publication Date Title
EP3169814A4 (en) Methods for evaluating lung cancer status
IL249868A0 (en) A method
SG11201608791UA (en) Method for completing a secure erase operation
ZA201606324B (en) Method for diagnosing tuberculosis
PL3196196T3 (en) Method for preparing calcobutrol
PL2915922T3 (en) Method for operating a vehicle barrier
SG11201701326YA (en) Method for producing oligosilane
IL252173A0 (en) Method for producing methyl-dichloro-phosphane
SG10201403766QA (en) A Method For Conducting A Transaction
PL2955295T3 (en) Method for manufacturing a panel
GB201402036D0 (en) Method for determination of the status of a disease
PL3186129T3 (en) Method for operating a vehicle
GB2552271B (en) A method for diagnosing lung cancer
PL3048312T3 (en) Method for establishing a profile connection
GB201507437D0 (en) Method for preparing a sorbent
GB201420832D0 (en) Location method
PL3107705T3 (en) Method for producing a composite part
GB201409851D0 (en) Diagnostic method
GB201406916D0 (en) Method for checking a vehicle
GB201415301D0 (en) An apparatus for forming a structure
GB201401055D0 (en) Method for diagnosing lung diseases
ZA201503784B (en) Tunneling method
GB201419634D0 (en) Lung cancer sub-typing method
GB201408875D0 (en) Diagnostic method
ZA201604816B (en) Method for producing a component

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20250605 AND 20250611